Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

STIM

Neuronetics Inc

Mar 21 • 04:00PM ET

4.86

Dollar change -0.08
Percentage change -1.62	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: COHR NOVA NVCR GNFT XFOR XERS SENS BLDR CANF

| Held by: VTI VXF PSIL IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.37	Insider Own	78.65%	Shs Outstand	55.68M	Perf Week	7.52%
Market Cap	194.73M	Forward P/E	-	EPS next Y	-0.23	Insider Trans	-0.54%	Shs Float	8.56M	Perf Month	1.25%
Income	-43.20M	PEG	-	EPS next Q	-0.12	Inst Own	18.84%	Short Float	23.20%	Perf Quarter	273.85%
Sales	74.89M	P/S	2.60	EPS this Y	77.06%	Inst Trans	21.17%	Short Ratio	1.30	Perf Half Y	414.39%
Book/sh	0.51	P/B	9.59	EPS next Y	27.77%	ROA	-34.66%	Short Interest	1.99M	Perf Year	13.82%
Cash/sh	0.49	P/C	9.91	EPS next 5Y	61.20%	ROE	-138.47%	52W Range	0.52 - 5.92	Perf YTD	201.86%
Dividend Est.	-	P/FCF	-	EPS past 5Y	2.87%	ROI	-40.74%	52W High	-17.91%	Beta	1.84
Dividend TTM	-	Quick Ratio	1.71	Sales past 5Y	4.64%	Gross Margin	70.15%	52W Low	834.62%	ATR (14)	0.49
Dividend Ex-Date	-	Current Ratio	1.85	EPS Y/Y TTM	-29.29%	Oper. Margin	-45.46%	RSI (14)	56.37	Volatility	7.40% 12.39%
Employees	203	Debt/Eq	2.93	Sales Y/Y TTM	4.96%	Profit Margin	-57.69%	Recom	1.50	Target Price	6.83
Option/Short	Yes / Yes	LT Debt/Eq	2.76	EPS Q/Q	-79.09%	Payout	-	Rel Volume	0.27	Prev Close	4.94
Sales Surprise	14.56%	EPS Surprise	-36.08%	Sales Q/Q	10.73%	Earnings	Mar 04 BMO	Avg Volume	1.53M	Price	4.86
SMA20	3.45%	SMA50	28.99%	SMA200	156.18%	Trades		Volume	408,575	Change	-1.62%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-13-24	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	William Blair	Outperform → Mkt Perform
Oct-13-21	Downgrade	BTIG Research	Buy → Neutral
Jan-22-21	Upgrade	William Blair	Mkt Perform → Outperform
Feb-06-20	Initiated	BTIG Research	Buy	$11
Jul-24-18	Initiated	Canaccord Genuity	Buy

Mar-18-25 09:55AM	Wall Street Analysts Think Neuronetics (STIM) Could Surge 34.98%: Read This Before Placing a Bet (Zacks)
Mar-05-25 02:06AM	Neuronetics Inc (STIM) Q4 2024 Earnings Call Highlights: Revenue Growth Amidst Rising Expenses ... (GuruFocus.com) +7.11%
Mar-04-25 11:29PM	Q4 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +18.78%
07:36AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Fourth Quarter and Full Year 2024 Financial and Operating Results (GlobeNewswire)
04:30PM	Loading…
Mar-03-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:20AM	Neuronetics Inc (STIM) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Feb-22-25 05:08PM	Neuronetics, Inc. (STIM): Among the Hot Penny Stocks to Buy Now (Insider Monkey)
Feb-21-25 08:30AM	Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) -13.96%
Feb-07-25 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -13.76% +25.73%
07:54AM	Neuronetics Announces Pricing of $18 Million Underwritten Public Offering of Common Stock (GlobeNewswire)
Feb-06-25 04:23PM	Neuronetics Announces Launch of Underwritten Public Offering of Common Stock (GlobeNewswire) +8.87%
Feb-03-25 07:27PM	Why Neuronetics Inc (STIM) Is Skyrocketing So Far In 2025 (Insider Monkey) +7.81%
Jan-29-25 08:31AM	NeuroStar Unveils Two Significant Publications on TMS Therapy for Depression (GlobeNewswire) +6.31%
Jan-13-25 08:00AM	Neuronetics Provides Business Update and Issues 2025 Guidance (GlobeNewswire) +36.84%
04:30PM	Loading…
Dec-18-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +5.38% -5.84%
Dec-16-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +19.27%
Dec-10-24 10:00AM	Neuronetics and Greenbrook TMS Announce Closing of Transaction (GlobeNewswire)
Nov-20-24 08:30AM	Neuronetics to Present at the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +6.26%
Nov-13-24 02:10AM	Neuronetics Inc (STIM) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses ... (GuruFocus.com) -11.65%
Nov-12-24 06:45PM	CORRECTION Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire) -37.27%
04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
08:20AM	Neuronetics (STIM) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
07:19AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:10AM	Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results (GlobeNewswire)
Nov-11-24 07:26AM	Neuronetics Inc (STIM) Q3 2024 Earnings Report Preview: What to Expect (GuruFocus.com) -5.98%
Oct-29-24 04:30PM	Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire) +5.94%
Oct-14-24 08:31AM	NeuroStar Oral Presentation at AACAP 2024 Highlights Largest Study Evaluating TMS Efficacy in Adolescents with Depression (GlobeNewswire)
Oct-04-24 08:33AM	Neuronetics and Greenbrook TMS Announce Receipt of Interim Order in Respect of Proposed Arrangement and Provide Details of Shareholder Meetings (PR Newswire) +7.58%
Sep-25-24 08:31AM	Health Care Service Corporation Adds First-Line TMS Coverage for Adolescents (GlobeNewswire) -6.18%
08:31AM	Loading…
Sep-19-24 08:31AM	Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults (GlobeNewswire)
Sep-16-24 08:32AM	NeuroStar Releases Software Upgrades to Elevate Patient Care (GlobeNewswire) +6.70%
Sep-03-24 08:29AM	NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories (GlobeNewswire)
Aug-20-24 08:29AM	NeuroStar Marks Two Years of Transformative Impact with NeuroStar University (GlobeNewswire)
Aug-15-24 05:42AM	Neuronetics inks Greenbrook merger to acquire treatment centers (MedTech Dive) +16.32%
Aug-13-24 12:56PM	Neuronetics' (STIM) Latest Deal to Aid Mental Health Treatments (Zacks)
12:47PM	Neuronetics (STIM) Inks a New Merger Agreement With Greenbrook (Zacks)
09:45AM	Neuronetics (STIM) Q2 Loss Wider Than Expected, Revenues Fall Y/Y (Zacks)
Aug-12-24 08:25AM	Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -58.15%
07:19AM	Neuronetics: Q2 Earnings Snapshot (Associated Press Finance)
07:15AM	Neuronetics and Greenbrook TMS Announce Definitive Agreement to Merge (GlobeNewswire)
07:10AM	Neuronetics Reports Record Second Quarter 2024 Financial and Operating Results (GlobeNewswire)
Aug-05-24 04:36PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-01-24 08:29AM	NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month (GlobeNewswire)
Jul-31-24 08:30AM	Neuronetics to Present at the Canaccord Genuity 44th Annual Growth Conference (GlobeNewswire)
Jul-30-24 08:30AM	Neuronetics Announces the Closing of up to $90 Million Senior Secured Credit Facility with Perceptive Advisors (GlobeNewswire)
Jul-29-24 08:30AM	Neuronetics to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Jul-22-24 08:31AM	Aetna Policy Update Expands TMS Availability for Adolescents With Depression (GlobeNewswire)
Jul-18-24 10:30AM	3 Neurotech Stocks Bridging Mind and Machine (InvestorPlace) -5.00%
Jul-11-24 12:53PM	TMS in California will have Medicaid coverage for major depressive disorder patients (Medical Device Network)
08:36AM	California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults (GlobeNewswire)
Jul-10-24 08:32AM	BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents (GlobeNewswire)
07:23AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday (InvestorPlace)
Jul-02-24 10:40AM	Neuronetics (STIM) Expands NeuroStar Portfolio With New Launch (Zacks)
Jul-01-24 08:02AM	NeuroStar Launches Better Me Provider Program Nationwide (GlobeNewswire)
Jun-13-24 08:31AM	NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting (GlobeNewswire)
Jun-07-24 02:38AM	Director Robert Cascella Acquires 50,000 Shares of Neuronetics Inc (STIM) (GuruFocus.com) +10.34%
May-23-24 08:30AM	Neuronetics to Present at the William Blair 44th Annual Growth Stock Conference (GlobeNewswire)
May-15-24 07:32AM	Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents (GlobeNewswire)
May-08-24 09:30AM	Neuronetics, Inc. (NASDAQ:STIM) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:15AM	Neuronetics Inc (STIM) (Q1 2024) Earnings Call Transcript Highlights: Strategic Growth Amidst ... (GuruFocus.com)
May-07-24 11:34PM	Q1 2024 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) -30.67%
08:58AM	Neuronetics Inc (STIM) Reports Q1 2024 Earnings: Revenue Surpasses Estimates, Narrowing Losses (GuruFocus.com)
08:40AM	Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:40AM	Neuronetics: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record First Quarter 2024 Financial and Operating Results (GlobeNewswire)
May-03-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) +8.86%
May-01-24 08:31AM	NeuroStar TMS Advances Treatment for Adolescents During Mental Health Awareness Month (GlobeNewswire) +5.49%
Apr-23-24 04:30PM	Neuronetics to Report First Quarter 2024 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Apr-10-24 08:31AM	New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital (GlobeNewswire)
Apr-01-24 10:52AM	Neuronetics' (STIM) FDA-Cleared NeuroStar to Aid in Depression (Zacks)
Mar-27-24 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
01:10AM	Neuronetics wins FDA clearance for device to treat adolescents with depression (MedTech Dive)
Mar-25-24 08:30AM	NeuroStar Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression (GlobeNewswire) +11.35%
Mar-08-24 08:06AM	Neuronetics (STIM) Progresses in MRD and TRD With New Deal (Zacks)
Mar-07-24 02:00PM	Neuronetics Inc (STIM) Reports Record Revenues in Q4 and Full Year 2023 (GuruFocus.com)
10:16AM	Neuronetics, Inc. (NASDAQ:STIM) Q4 2023 Earnings Call Transcript (Insider Monkey)
08:22AM	Neuronetics Announces 5-Year Exclusive Partnership with Transformations Care Network (GlobeNewswire)
Mar-05-24 11:39PM	Q4 2023 Neuronetics Inc Earnings Call (Thomson Reuters StreetEvents) +15.41% +24.84%
08:40AM	Neuronetics (STIM) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:46AM	Neuronetics: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Record Fourth Quarter and Record Full Year 2023 Financial and Operating Results (GlobeNewswire)
Feb-20-24 08:30AM	Neuronetics to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Feb-12-24 08:32AM	Neuronetics Launches Latest Evolution in its TrakStar Patient Data Management System (GlobeNewswire)
Feb-06-24 08:28AM	NeuroStar TMS Patient Access Expands Through Lucet Health Policy Update (GlobeNewswire) +6.67%
Jan-08-24 08:30AM	Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2023 Financial Results (GlobeNewswire) -6.35%
Dec-18-23 08:49AM	Neuronetics Receives 510(k) Clearance for NeuroSite Coil Placement Accessory (GlobeNewswire)
Dec-04-23 08:56AM	NeuroStar TMS Receives Expanded Regulatory Approval in Japan (GlobeNewswire) +8.87%
Nov-15-23 04:15PM	Neuronetics to Present at the 35th Annual Piper Sandler Healthcare Conference (GlobeNewswire)
Nov-13-23 08:57AM	NeuroStar Elevates Depression Treatment with Cutting-Edge Technology Advancements (GlobeNewswire)
Nov-09-23 08:32AM	Neuronetics Announces Continued Momentum from Health Plans for TMS Therapy Coverage (GlobeNewswire) -11.30%
Nov-08-23 01:16PM	Neuronetics, Inc. (NASDAQ:STIM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:57AM	Neuronetics Inc (STIM) Reports 8% Revenue Growth in Q3 2023 (GuruFocus.com) +8.11%
07:43AM	Neuronetics: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Neuronetics Reports Third Quarter 2023 Financial and Operating Results (GlobeNewswire)
Nov-06-23 04:30PM	Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -7.50%
Oct-24-23 08:30AM	Neuronetics to Report Third Quarter 2023 Financial and Operating Results and Host Conference Call (GlobeNewswire)
Oct-16-23 08:56AM	Brain Stimulation Highlights Best Practices for Optimal TMS Treatment Outcomes (GlobeNewswire)
Oct-03-23 09:21AM	Neuronetics Draws Down Remaining $22.5 Million Available Under Credit Facility (GlobeNewswire) -6.87%
Sep-12-23 08:56AM	In Recognition of Suicide Prevention Month, NeuroStar Voices Portal Amplifies Stories of Real People Beating Depression (GlobeNewswire)

Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Furlong Stephen	EVP, CFO and Treasurer	Mar 04 '25	Sale	4.48	1,867	8,364	610,053	Mar 06 05:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Mar 04 '25	Sale	4.48	377	1,689	526,805	Mar 06 05:00 PM
MACAN WILLIAM ANDREW	Officer	Mar 04 '25	Proposed Sale	4.48	377	1,688		Mar 04 03:27 PM
Furlong Stephen	Officer	Mar 04 '25	Proposed Sale	4.48	1,867	8,360		Mar 04 03:16 PM
Sullivan Keith J	President and CEO	Feb 19 '25	Sale	4.70	24,440	114,868	1,232,988	Feb 20 05:21 PM
Sullivan Keith J	President and CEO	Feb 18 '25	Sale	4.41	25,934	114,369	1,257,428	Feb 20 05:21 PM
Sullivan Keith J	Officer	Feb 19 '25	Proposed Sale	4.70	24,440	114,760		Feb 19 03:16 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 14 '25	Sale	4.11	18,965	77,946	369,682	Feb 18 05:03 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 14 '25	Sale	4.11	17,307	71,132	454,420	Feb 18 05:02 PM
Sullivan Keith J	Officer	Feb 18 '25	Proposed Sale	4.41	25,934	114,356		Feb 18 03:16 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 12 '25	Sale	3.83	10,845	41,536	471,727	Feb 14 05:00 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 12 '25	Sale	3.83	12,175	46,630	388,647	Feb 14 05:00 PM
Furlong Stephen	Officer	Feb 14 '25	Proposed Sale	4.11	17,307	71,158		Feb 14 03:13 PM
MACAN WILLIAM ANDREW	Officer	Feb 14 '25	Proposed Sale	4.11	18,965	77,975		Feb 14 03:13 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Feb 10 '25	Sale	3.28	1,970	6,462	400,822	Feb 12 05:05 PM
Sullivan Keith J	President and CEO	Feb 10 '25	Sale	3.28	40,992	134,454	1,283,362	Feb 12 05:05 PM
Furlong Stephen	EVP, CFO and Treasurer	Feb 10 '25	Sale	3.28	14,836	48,662	482,572	Feb 12 05:05 PM
Furlong Stephen	Officer	Feb 12 '25	Proposed Sale	3.83	10,845	41,554		Feb 12 03:17 PM
MACAN WILLIAM ANDREW	Officer	Feb 12 '25	Proposed Sale	3.83	12,175	46,650		Feb 12 03:08 PM
Sullivan Keith J	Officer	Feb 10 '25	Proposed Sale	3.28	40,992	134,466		Feb 10 03:17 PM
MACAN WILLIAM ANDREW	Officer	Feb 10 '25	Proposed Sale	3.28	1,970	6,462		Feb 10 03:16 PM
Furlong Stephen	Officer	Feb 10 '25	Proposed Sale	3.28	14,836	48,667		Feb 10 03:13 PM
Furlong Stephen	EVP, CFO and Treasurer	Oct 08 '24	Sale	0.82	1,368	1,122	497,408	Oct 10 05:05 PM
MACAN WILLIAM ANDREW	EVP, GC, CCO and CS	Oct 08 '24	Sale	0.82	1,541	1,264	402,792	Oct 10 05:05 PM
Furlong Stephen	Officer	Oct 08 '24	Proposed Sale	0.82	1,368	1,116		Oct 08 03:20 PM
MACAN WILLIAM ANDREW	Officer	Oct 08 '24	Proposed Sale	0.82	1,541	1,257		Oct 08 03:19 PM
CASCELLA ROBERT	Director	Sep 12 '24	Buy	0.75	100,000	75,000	453,098	Sep 13 05:02 PM
MUIR GLENN P	Director	Sep 05 '24	Buy	0.80	25,000	20,000	289,818	Sep 06 05:05 PM
MUIR GLENN P	Director	Aug 28 '24	Buy	0.85	12,776	10,860	252,594	Aug 30 05:15 PM
MUIR GLENN P	Director	Aug 29 '24	Buy	0.85	12,224	10,390	264,818	Aug 30 05:15 PM
MUIR GLENN P	Director	Aug 20 '24	Buy	1.00	25,000	25,000	239,818	Aug 21 05:15 PM
CASCELLA ROBERT	Director	Aug 16 '24	Buy	1.06	35,000	37,100	349,098	Aug 19 05:13 PM
CASCELLA ROBERT	Director	Aug 19 '24	Buy	1.14	4,000	4,560	353,098	Aug 19 05:13 PM
CASCELLA ROBERT	Director	Aug 15 '24	Buy	0.88	35,000	30,800	314,098	Aug 16 05:15 PM
CASCELLA ROBERT	Director	Aug 14 '24	Buy	0.79	35,000	27,650	279,098	Aug 16 05:15 PM
MUIR GLENN P	Director	Aug 14 '24	Buy	0.75	25,171	18,878	214,818	Aug 16 05:15 PM
Sullivan Keith J	President and CEO	Jul 18 '24	Sale	1.90	24,162	45,908	1,324,354	Jul 22 05:23 PM
Sullivan Keith J	President and CEO	Jul 16 '24	Sale	1.91	12,075	23,063	1,360,203	Jul 18 05:21 PM
Sullivan Keith J	President and CEO	Jul 17 '24	Sale	1.97	11,687	23,023	1,348,516	Jul 18 05:21 PM
CASCELLA ROBERT	Director	Jun 06 '24	Buy	2.05	50,000	102,550	244,098	Jun 06 05:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

STIM

Neuronetics Inc

Upgrade your FINVIZ experience